CRL
$302.00 · +1.0% today · +0.6% 5d · +31.8% 3m · +77.0% 1y
Daily score45
Weekly score33
Long-term score96
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
302.00
1D return
+1.0%
5D return
+0.6%
Rel volume
0.91
CMF 20
0.06
OBV slope 20
-0.03
Up-vol ratio 10
0.40
Short ratio
0.71
Short ratio Δ
−0.3%
Persistence 10
0.00
Inflow mean 5d
-0.20
Inflow mean 60d
0.24
Momentum 12-1
+59.9%
% of 52w high
+97.2%
vs 200d
+41.1%
Volatility 60d
+42.5%
Dollar vol 20d
$302.04M
Insider buys 90d
$3.0K
Insider buyers 90d
1.00
Revenue growth
−2.7%
Fundamentals — Charles River Laboratories · Health Care
as of 2026-10-22- P/E
- —
- P/B
- 5.71
- ROE
- -5.1%
- Operating margin
- 0.6%
- Debt / equity
- 0.00
- FCF yield
- 4.5%
- Years profitable
- 4/5
- BM score
- 6
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-23 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Sell | 2.2K | $344.41 | $742.5K |
| 2026-10-07 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Sell | 981 | $308.44 | $302.6K |
| 2026-10-02 | Coleman Glenn | EVP & Chief Financial Officer | Buy | 10 | $297.43 | $3.0K |
| 2026-08-27 | FOSTER JAMES C | Director | Sell | 33.6K | $300.00 | $10.07M |
| 2026-08-20 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Sell | 2.0K | $294.12 | $599.7K |
| 2026-08-20 | Andrews Nancy C | Director | Sell | 573 | $285.24 | $163.4K |
| 2026-08-13 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Sell | 3.7K | $279.66 | $1.04M |
| 2026-08-13 | Girshick Birgit | Chief Executive Officer | Sell | 6.5K | $279.90 | $1.82M |
| 2026-08-11 | FOSTER JAMES C | Director | Sell | 28.7K | $275.00 | $7.90M |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 810 | $261.45 | $211.8K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 213 | $262.37 | $55.9K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 620 | $263.94 | $163.6K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 736 | $258.53 | $190.3K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 404 | $258.53 | $104.4K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 1.2K | $258.53 | $311.5K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 482 | $265.17 | $127.8K |
| 2026-08-10 | Creamer Victoria L | EVP & Chief People Officer | Sell | 4.2K | $259.16 | $1.08M |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 1.3K | $259.07 | $330.1K |
| 2026-08-10 | Knell Michael Gunnar | SVP, Finance and CAO | Sell | 901 | $260.63 | $234.8K |
| 2026-08-06 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Sell | 5.0K | $263.00 | $1.33M |
| 2026-07-01 | FOSTER JAMES C | Director | Sell | 75.0K | $225.00 | $16.88M |
Congress trades
No congressional trades on file for CRL.